Gonadotropin-producing pituitary adenoma in a man with long-standing primary hypogonadism.
Pituitary adenomas that secrete gonadotropins are generally believed to arise spontaneously rather than as a response to chronic primary gonadal failure. However, two women who were found to have gonadotroph adenomas several years after ovarian ablation have been reported. We describe a middle-aged man who developed bitemporal hemianopia and was found to have a large pituitary tumor 35 yr after castration. He had never received any replacement therapy. The tumor was considered to be a primary gonadotroph adenoma, rather than secondary gonadotroph hyperplasia, on the basis of its secretory capabilities, its reticulin patterns, and its specific immunostaining for human FSH beta, human LH beta, and alpha-subunit. Furthermore, the tumor did not decrease appreciably in size after 12 months of testosterone treatment, although plasma gonadotropin levels decreased. Unless the association of primary gonadal failure with a gonadotroph adenoma was coincidental, it suggests that some human gonadotroph adenomas may be secondary to failure of the gonads.
D000236:Adenoma / Q000150:complications* / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D005640:Follicle Stimulating Hormone / Q000378:metabolism*; D015292:Glycoprotein Hormones, alpha Subunit; D006651:Histocytochemistry; D006801:Humans; D007006:Hypogonadism / Q000150:complications* / Q000473:pathology; D007986:Luteinizing Hormone / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010908:Pituitary Hormones, Anterior / Q000378:metabolism; D010911:Pituitary Neoplasms / Q000150:complications* / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D013739:Testosterone / Q000627:therapeutic use
D015292:Glycoprotein Hormones, alpha Subunit; D010908:Pituitary Hormones, Anterior; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone